Depo-Provera Lawsuit

Last Updated: August 8, 2026 | Published by: Mason Arnao | Primary Sources: U.S. District Court, N.D. Florida (MDL 3140); AboutLawsuits.com; FDA Quick Answer: A confidential Depo-Provera lawsuit settlement now covers nearly 6,300 federal meningioma brain-tumor claims after attorneys finalized a Master Settlement Agreement on July 27, 2026. Full eligibility and payout details will be [...]

Quick Answer: The Depo-Provera lawsuit statute of limitations typically runs one to six years from the date of diagnosis, depending on your state and whether that state applies a "discovery rule." Missing your state's deadline can bar your claim entirely, so confirming your exact filing window with an attorney as soon as possible is critical. [...]

The Depo-Provera Rule 702 hearing on general causation moves to July 27, 2026. Here's what the ruling could mean if your case isn't covered by the settlement.

Quick Answer: A Depo-Provera settlement was announced on June 15, 2026, covering a majority of the claims in MDL 3140 and New York state court that the injectable birth control caused meningioma brain tumors. The parties signed a confidential Master Settlement Agreement on July 21, 2026 and estimated that roughly 80% of MDL plaintiffs would [...]

Update — September 24, 2026: A settlement has been reached. On June 15, 2026, plaintiffs’ leadership counsel announced a settlement with Pfizer of a majority of the claims in Depo-Provera MDL 3140 — before Judge M. Casey Rodgers in the U.S. District Court for the Northern District of Florida — and in New York state [...]

Depo-Provera brain tumor claims allege that long-term use of injectable medroxyprogesterone acetate raises the risk of intracranial meningioma and that patients were never adequately warned. Who qualifies in 2026: the diagnosis and use history required, the records that matter, and filing deadlines.

The June 24-26, 2026 Rule 702 hearing before Judge M. Casey Rodgers tests whether plaintiffs' causation experts can tell a jury that Depo-Provera causes intracranial meningioma. With roughly 6,000 claims in MDL No. 3140, why this ruling shapes the litigation and who qualifies.

Short answer: Depo-Provera (medroxyprogesterone acetate) has been linked to an elevated risk of intracranial meningioma — a type of brain tumor. Over 12,000 lawsuits have been filed against Pfizer as of 2026, consolidated into a federal MDL in the Northern District of Illinois. Women who used Depo-Provera for one year or more and later developed [...]

An agreement in principle to resolve eligible federal Depo-Provera claims was announced on June 15, 2026 with no financial terms disclosed, so no per-claim settlement value has been published. What drives claim value in MDL No. 3140 - tumor severity, surgery, lost income, and proof of use.

Depo-Provera lawsuit update May 2026: MDL 3140 at 3,769+ cases, Daubert hearings active, statutes of limitations running. Who qualifies, settlement amounts. Call 855-664-8713.

Can you sue Depo-Provera for meningioma? Yes — 3,769+ cases in MDL 3140 against Pfizer. Eligibility, settlement amounts $50K–$500K+, how to file for free. Call 855-664-8713.

Depo-Provera meningioma lawsuit 2026: FDA-confirmed link between Depo-Provera and meningioma brain tumors. 3,769+ cases in MDL 3140. Who qualifies, settlement amounts, and how to file. Call 855-664-8713.

The Depo-Provera lawsuit 2026 is at a critical juncture with 3,790+ meningioma cases in MDL 3140 awaiting Daubert rulings. Learn who qualifies, settlement estimates, and how to file your claim before the deadline.

Breaking Depo-Provera lawsuit update: Pfizer files Daubert motion in the meningioma MDL ahead of June 24–26 causation hearings. 3,790 plaintiffs, settlement estimates $100K–$1.5M, who qualifies in 2026. Call 855-664-8713 for a free case review.

Get the latest Depo-Provera lawsuit update: 1,775+ MDL cases, meningioma risks, eligibility, settlements & how to join now.

Hire a Depo-Provera lawsuit attorney now. Fight Pfizer for meningioma risks from injections. Free consult, MDL updates & settlements up to $1.5M.